Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 8.79B 1.31B 1.15B 1.09B 988M 1.85B 126B 1.87B 13.04B 5.04B 64.13B 4.92B 4.81B 206B P/E 2026 *
86.9x
P/E 2027 * 66.4x
Enterprise Value 8.79B 1.31B 1.15B 1.09B 988M 1.85B 126B 1.87B 13.04B 5.04B 64.13B 4.92B 4.81B 206B EV / Sales 2026 *
8.06x
EV / Sales 2027 * 7.1x
Free-Float
62.75%
Yield 2026 *
-
Yield 2027 * -
09-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd.(XSEC:301188) added to S&P Global BMI Index CI
08-24 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
04-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
04-06 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
03-31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
12-15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
12-14 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
11-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
27/10/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
09/10/25 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
1 day-4.43%
1 week-5.63%
Current month-9.97%
1 month-8.41%
3 months-52.38%
6 months+99.06%
Current year+92.50%
1 week 33.3
Extreme 33.3
38.86
1 month 30.59
Extreme 30.59
38.86
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 14/04/2024
Director of Finance/CFO 45 28/11/2022
Investor Relations Contact - -
Director TitleAgeSince
Chairman 51 30/10/2025
Chairman 47 31/12/2023
Director/Board Member 54 05/04/2015
Change 5-day change 1-year change 3-year change Capi.($)
-4.43%-5.63%+96.29%+164.89% 1.31B
-0.45%-0.34%+4.41%+25.62% 3.56B
-0.28%-5.58%-25.17%-52.79% 2.5B
+0.11%-2.67%-14.54%-34.58% 1.8B
-1.37%-5.09%-56.05%-66.10% 888M
-5.43%-7.62%+50.79%+47.93% 671M
-0.31%-2.12%-16.19%-54.37% 651M
-1.37%-2.52%+46.61%+77.38% 632M
+0.42%-2.36%-18.72%-52.98% 453M
-1.19%-3.85%+70.14%+95.04% 321M
Average -1.43%-3.54%+13.76%+15.00% 1.28B
Weighted average by Cap. -1.10%-2.91%+5.46%+8.30%

Financials

2026 *2027 *
Net sales 1.09B 162M 143M 135M 122M 230M 15.58B 231M 1.62B 624M 7.95B 610M 596M 25.55B 1.24B 184M 162M 153M 139M 261M 17.7B 263M 1.84B 709M 9.03B 692M 677M 29.02B
Net income 103M 15.34M 13.49M 12.76M 11.57M 21.73M 1.47B 21.86M 153M 59M 751M 57.6M 56.35M 2.41B 137M 20.41M 17.95M 16.97M 15.39M 28.91M 1.96B 29.08M 203M 78.48M 1B 76.61M 74.95M 3.21B
Net Debt - -
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
28/09/26 CN¥33.88 -4.43% 17,499,769
24/09/26 CN¥35.45 -3.83% 16,797,659
23/09/26 CN¥36.86 +4.45% 25,332,282
22/09/26 CN¥35.29 -1.70% 18,928,025

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 301188 Stock